Chia Jie Tan,Melinda Si Yun Tan,Chandramouli Nagarajan,Wee Joo Chng,Yen Lin Chee,Melissa Ooi,Lawrence Cheng Kiat Ng,Yunxin Chen,Joanne Su Yin Yoong,Xin Yi Wong,Wei‐Ying Jen
出处
期刊:JCO oncology practice [American Society of Clinical Oncology] 日期:2023-10-16卷期号:19 (12): 1168-1178
Treatment options for myeloma and indolent lymphoma are increasing exponentially, with distinct efficacy, side effects, and cost. We aim to determine the factors influencing patient and caregiver treatment preferences.